GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovaQor Inc (OTCPK:INQR) » Definitions » Shares Outstanding (EOP)

InnovaQor (InnovaQor) Shares Outstanding (EOP) : 244.95 Mil (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is InnovaQor Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. InnovaQor's shares outstanding for the quarter that ended in Sep. 2023 was 244.95 Mil.

InnovaQor's quarterly shares outstanding stayed the same from Jun. 2023 (244.95 Mil) to Sep. 2023 (244.95 Mil).

InnovaQor's annual shares outstanding increased from Dec. 2021 (234.95 Mil) to Dec. 2022 (244.95 Mil). It means InnovaQor issued new shares from Dec. 2021 to Dec. 2022 .


InnovaQor Shares Outstanding (EOP) Historical Data

The historical data trend for InnovaQor's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovaQor Shares Outstanding (EOP) Chart

InnovaQor Annual Data
Trend Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Dec21 Dec22
Shares Outstanding (EOP)
Get a 7-Day Free Trial 42.14 44.16 47.51 234.95 244.95

InnovaQor Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 234.95 244.95 244.95 244.95 244.95

Competitive Comparison of InnovaQor's Shares Outstanding (EOP)

For the Health Information Services subindustry, InnovaQor's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovaQor's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovaQor's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where InnovaQor's Shares Outstanding (EOP) falls into.



InnovaQor Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


InnovaQor  (OTCPK:INQR) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


InnovaQor Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of InnovaQor's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovaQor (InnovaQor) Business Description

Traded in Other Exchanges
N/A
Address
400 S. Australian Avenue, Suite 800, West Palm Beach, FL, USA, 33401
InnovaQor Inc provides information technology solutions and services to healthcare and laboratory customers in the United States. Its goal is to develop and deliver a technology-based medical professional's network communication platform to a broad range of healthcare professionals and businesses using a subscription revenue model with added value bolt-on services.
Executives
Francisco Iii Roca director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Darrell L Peterson director, officer: Chief Executive Officer 2390 CIRCLE DRIVE, WEST PALM BEACH FL 33406
Sharon Lynne Hollis director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Justin Doherty director 400 S. AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Thomas Joseph Bellante officer: Chief Financial Officer 14706 CROYDON PLACE, TAMPA FL 33618
Jayne Kirby officer: VP Finance 1035 LAURIER O., SUITE 200, MONTREAL A8 H2V 2L1
Arthur Gelston 10 percent owner 1035 LAURIER STREET WEST, MONTREAL A8 H2V 2L1
Visual Healthcare Corp 10 percent owner 790 ROCKLAND AVE., MONTREAL, QC. A8 H2V 2Z6
Philippe Rainville officer: CFO 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Philippe Panzini director 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Michel Maksud officer: VP Technology 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Gerard Dab director, officer: CEO and Chairman of the Board 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Louis J Lombardo director 108 SMITH LAKE ROAD, ROSCOE NY 12776
Visualmed Clinical Systems Corp 10 percent owner
Barry Scharf officer: VP Operations 391A LAURIER WEST, MONTREAL A8 H2V 2K3